These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33821250)

  • 41. Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection.
    Zhu H; Fu L; Jin Y; Shao J; Zhang S; Zheng N; Fan L; Yu Z; Ying J; Hu Y; Chen T; Chen Y; Chen M; Chen M; Xiong Z; Kang J; Jin J; Cai T; Ye H
    J Clin Lab Anal; 2020 Jul; 34(7):e23392. PubMed ID: 32506726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
    Taeschler P; Adamo S; Deng Y; Cervia C; Zurbuchen Y; Chevrier S; Raeber ME; Hasler S; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Bodenmiller B; Boyman O; Nilsson J
    Allergy; 2022 Aug; 77(8):2468-2481. PubMed ID: 35567391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19.
    Yang J; Zhong M; Zhang E; Hong K; Yang Q; Zhou D; Xia J; Chen YQ; Sun M; Zhao B; Xiang J; Liu Y; Han Y; Xu M; Zhou X; Huang C; Shang Y; Yan H
    J Mol Cell Biol; 2021 Jul; 13(3):197-209. PubMed ID: 33751111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
    Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of pre-existing and induced SARS-CoV-2-specific CD8
    Schulien I; Kemming J; Oberhardt V; Wild K; Seidel LM; Killmer S; Sagar ; Daul F; Salvat Lago M; Decker A; Luxenburger H; Binder B; Bettinger D; Sogukpinar O; Rieg S; Panning M; Huzly D; Schwemmle M; Kochs G; Waller CF; Nieters A; Duerschmied D; Emmerich F; Mei HE; Schulz AR; Llewellyn-Lacey S; Price DA; Boettler T; Bengsch B; Thimme R; Hofmann M; Neumann-Haefelin C
    Nat Med; 2021 Jan; 27(1):78-85. PubMed ID: 33184509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
    Zhang J; Wu Q; Liu Z; Wang Q; Wu J; Hu Y; Bai T; Xie T; Huang M; Wu T; Peng D; Huang W; Jin K; Niu L; Guo W; Luo D; Lei D; Wu Z; Li G; Huang R; Lin Y; Xie X; He S; Deng Y; Liu J; Li W; Lu Z; Chen H; Zeng T; Luo Q; Li YP; Wang Y; Liu W; Qu X
    Nat Microbiol; 2021 Jan; 6(1):51-58. PubMed ID: 33199863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology.
    Singh AK; Kasarpalkar N; Bhowmick S; Paradkar G; Talreja M; Shah K; Tiwari A; Palav H; Kaginkar S; Kulkarni R; Patil A; Kalsurkar V; Agrawal S; Shastri J; Dere R; Bharmal R; Mahale SD; Bhor VM; Patel V
    J Leukoc Biol; 2022 Jun; 111(6):1287-1295. PubMed ID: 35075682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.
    Koutsakos M; Rowntree LC; Hensen L; Chua BY; van de Sandt CE; Habel JR; Zhang W; Jia X; Kedzierski L; Ashhurst TM; Putri GH; Marsh-Wakefield F; Read MN; Edwards DN; Clemens EB; Wong CY; Mordant FL; Juno JA; Amanat F; Audsley J; Holmes NE; Gordon CL; Smibert OC; Trubiano JA; Hughes CM; Catton M; Denholm JT; Tong SYC; Doolan DL; Kotsimbos TC; Jackson DC; Krammer F; Godfrey DI; Chung AW; King NJC; Lewin SR; Wheatley AK; Kent SJ; Subbarao K; McMahon J; Thevarajan I; Nguyen THO; Cheng AC; Kedzierska K
    Cell Rep Med; 2021 Mar; 2(3):100208. PubMed ID: 33564749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased circulating level of interleukin-6 and CD8
    Yang PH; Ding YB; Xu Z; Pu R; Li P; Yan J; Liu JL; Meng FP; Huang L; Shi L; Jiang TJ; Qin EQ; Zhao M; Zhang DW; Zhao P; Yu LX; Wang ZH; Hong ZX; Xiao ZH; Xi Q; Zhao DX; Yu P; Zhu CZ; Chen Z; Zhang SG; Ji JS; Wang FS; Cao GW
    Infect Dis Poverty; 2020 Nov; 9(1):161. PubMed ID: 33239109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between immune response and self-reported depression during convalescence from COVID-19.
    Yuan B; Li W; Liu H; Cai X; Song S; Zhao J; Hu X; Li Z; Chen Y; Zhang K; Liu Z; Peng J; Wang C; Wang J; An Y
    Brain Behav Immun; 2020 Aug; 88():39-43. PubMed ID: 32464158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
    McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
    Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
    [No Abstract]   [Full Text] [Related]  

  • 54. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
    Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
    Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
    Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-cell landscape of immunological responses in patients with COVID-19.
    Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
    Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months.
    Zheng Y; Zhang Q; Ali A; Li K; Shao N; Zhou X; Ye Z; Chen X; Cao S; Cui J; Zhou J; Wang D; Hou B; Li M; Cui M; Deng L; Sun X; Zhang Q; Yang Q; Li Y; Wang H; Lei Y; Yu B; Cheng Y; Tong X; Men D; Zhang XE
    Virol Sin; 2021 Oct; 36(5):869-878. PubMed ID: 33661489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.
    Ling Y; Xu SB; Lin YX; Tian D; Zhu ZQ; Dai FH; Wu F; Song ZG; Huang W; Chen J; Hu BJ; Wang S; Mao EQ; Zhu L; Zhang WH; Lu HZ
    Chin Med J (Engl); 2020 May; 133(9):1039-1043. PubMed ID: 32118639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
    Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
    Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.